One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Coagulation Analyzers Market

[ 英語タイトル ] Coagulation Analyzers Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0084190
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 112
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Nihon Kohden Corporation
- F. Hoffmann-La Roche Ltd
- Siemens Healthcare
- DMS Imaging
- Sysmex Corporation
- Thermo Fisher Scientific Inc
- Diagnostica Stago Sas
- Helena Laboratories
- Instrumentation Laboratory
- Beckman Coulter Inc.

[Report Description]

Coagulation Analyzers are used for detecting the presence of blood clots in the blood vessels. These analyzers measure coagulation pathway speed as well as thrombolin & thromboplastin levels in a few minutes. A coagulation analyzer system also has built-in quality control and security lockout protocols to ensure safe and secure use, as it is used on sensitive information about patient's health.

The global coagulant analyzer market is driven by rise in the geriatric population, an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation. However, the high cost of fully automated coagulation analyzer and slow adoption of advanced hemostasis instruments in developing and underdeveloped economies are restraining the market growth.

Key Market Trends

D-Dimer Testing is Expected to Dominate the Market During the Forecast Period

D-dimer is one of the protein fragments produced when a blood clot gets dissolved in the body. It is usually undetectable or detectable at a very low amount unless the body is forming and breaking down blood clots. Then, its level in the blood can significantly rise. This test detects D-dimer in the blood.

It has been observed by the studies that an increased D-dimer and t-PA antigen levels are associated with Coronary Heart Disease (CHD) risk. As deaths due to Cardiovascular disease is expected to increase, the need for instruments used for analyzing D-Dimer is expected to increase, as this will help to understand CHD better. For instance, the World Health Organization has stated that cardiovascular diseases are the number one cause of deaths across the globe taking an estimated 17.9 million lives each year. Therefore, rising mortality associated with cardiovascular diseases is believed to augment the demand for D-Dimer testing.

North America is Expected to Dominate the Coagulation Analyzers Market

North America holds the largest share of the coagulation analyzers market which is majorly attributed to the well-established healthcare system acorss the countries such as United States and Canada and the large market of medical devices which is due to the presence of all international companies.

Asia-Pacific region is expected to witness rapid growth in the future which is due to the increasing adoption of technology and focus of the healthcare companies to enter the emerging economies such as India.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. The competition is fierce due to the consolidated nature of the market with top companies reporting to occupy major share in the market. The key players in the market are adopting various strategic moves to sustain the intense competition.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Blood Disorders
4.2.2 Rising Geriatric Population Coupled with Increasing Prevalence of Chronic Diseases
4.2.3 Increasing Laboratory Automation
4.3 Market Restraints
4.3.1 Slow Adoption Rate in Underdeveloped Economies
4.3.2 High Cost of Test for Fully Automated Analyzers
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Analyzers Clinical Laboratory Analyzers Point of Care Analyzers
5.1.2 Consumables
5.2 By Test Type
5.2.1 Fibrinogen Testing
5.2.2 D-Dimer Testing
5.2.3 Platelet Function Tests
5.2.4 Other Coagulation Tests
5.3 By Technology
5.3.1 Optical Technology
5.3.2 Mechanical Technology
5.3.3 Electrochemical Technology
5.3.4 Others
5.4 By End User
5.4.1 Hospitals
5.4.2 Diagnostic Centers
5.4.3 Others
5.5 Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.5.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Nihon Kohden Corporation
6.1.2 F. Hoffmann-La Roche Ltd
6.1.3 Siemens Healthcare
6.1.4 DMS Imaging
6.1.5 Sysmex Corporation
6.1.6 Thermo Fisher Scientific Inc
6.1.7 Diagnostica Stago Sas
6.1.8 Helena Laboratories
6.1.9 Instrumentation Laboratory
6.1.10 Beckman Coulter Inc.




Recommended reports